Ken Griffin’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,999,470
Closed -$288M 9104
2014
Q3
$259M Buy
2,999,470
+1,585,895
+112% +$140M 0.27% 42
2014
Q2
$127M Sell
1,413,575
-185,379
-12% -$13.9M 0.15% 114
2014
Q1
$118M Buy
1,598,954
+1,514,281
+1,788% +$106M 0.14% 126
2013
Q4
$5.77M Buy
84,673
+43,478
+106% +$2.83M 0.01% 1574
2013
Q3
$2.51M Sell
41,195
-185,266
-82% -$11.3M ﹤0.01% 2193
2013
Q2
$12.6M Buy
+226,461
New +$13.1M 0.02% 913

Ken Griffin's COV Position: Q4 2014 in Review

Ken Griffin sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 2,999,470 shares — an estimated $288M sold.

Ken Griffin first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $259M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Ken Griffin reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
  • Ken Griffin sold 2,999,470 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $288M.
  • Ken Griffin first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Ken Griffin's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $259M in Q3 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.